Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: A comparative analysis across two New York hospitals

A large range of prognostic models for determining the risk of COVID-19 patient mortality exist, but these typically restrict the set of biomarkers considered to measurements available at patient admission. Additionally, many of these models are trained and tested on patient cohorts from a single ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Ben, Stopard, Isaac J., Momeni-Boroujeni, Amir, Mendoza, Rachelle, Zuretti, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387798/
https://www.ncbi.nlm.nih.gov/pubmed/35981055
http://dx.doi.org/10.1371/journal.pone.0272442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387798/
https://www.ncbi.nlm.nih.gov/pubmed/35981055
http://dx.doi.org/10.1371/journal.pone.0272442

Ejemplares similares